SCHEMBL22633366

SCHEMBL22633366

CCOCC(COCCO)OCCO

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.54
TSHR P16473 2/20 0.43
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
THRB P10828 1/20 0.39
HTT P42858 1/20 0.39
MAPT P10636 1/20 0.39
LPAR1 Q92633 6/20 0.39
LPAR3 Q9UBY5 6/20 0.39
LPAR2 Q9HBW0 3/20 0.39
MAPK1 P28482 1/20 0.38
USP2 O75604 1/20 0.34
LPAR6 P43657 2/20 0.33
LPAR4 Q99677 2/20 0.33
LPAR5 Q9H1C0 2/20 0.33
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.31
TLR2 O60603 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14642721 0.91 ALDH1A1 (0.48) ALDH1A1TSHRMEN1KMT2ATHRB
SCHEMBL1357542 0.89 TSHR (0.47) ALDH1A1TSHRMEN1KMT2ATHRB
SCHEMBL23768408 0.88 ALDH1A1 (0.56) ALDH1A1TSHRMEN1KMT2ATHRB
SCHEMBL19543564 0.88 ALDH1A1 (0.56) ALDH1A1TSHRMEN1KMT2ATHRB
SCHEMBL13563001 0.87 TSHR (0.48) ALDH1A1TSHRMEN1KMT2ATHRB
SCHEMBL8522872 0.87 ALDH1A1 (0.48) ALDH1A1TSHRMEN1KMT2ATHRB
SCHEMBL12024300 0.87 TSHR (0.48) ALDH1A1TSHRMEN1KMT2ATHRB
SCHEMBL18738907 0.87 LPAR1 (0.55) ALDH1A1TSHRMEN1KMT2ATHRB
SCHEMBL5502602 0.86 TSHR (0.45) ALDH1A1TSHRMEN1KMT2ATHRB
SCHEMBL19543524 0.86 MEN1 (0.50) ALDH1A1TSHRMEN1KMT2ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12453785-B2 Macrocyclic chelators and methods of use thereof JANSSEN BIOTECH, INC. (US) 2025-10-28 US disclosed
CN-114127059-B Macrocyclic chelators and methods of use thereof 詹森生物科技公司 2024-09-24 CN disclosed
US-20230110178-A1 Macrocyclic Chelators and Methods of Use Thereof JANSSEN BIOTECH, INC. 2023-04-13 US disclosed
US-11576986-B2 Macrocyclic chelators and methods of use thereof JANSSEN BIOTECH, INC. (US) 2023-02-14 US disclosed
CN-114127059-A Macrocyclic chelants and methods of use thereof 詹森生物科技公司 2022-03-01 CN disclosed
US-20200353105-A1 Macrocyclic Chelators and Methods of Use Thereof JANSSEN BIOTECH, INC. 2020-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200353105-A1 Macrocyclic Chelators and Methods of Use Thereof CLASP1, CLTC, CD47 ALDH1A1 2977/4885TSHR 225/4885MEN1 173/4885
US-11576986-B2 Macrocyclic chelators and methods of use thereof CLASP1, CLTC, CD47 ALDH1A1 2977/4885TSHR 225/4885MEN1 173/4885
US-20230110178-A1 Macrocyclic Chelators and Methods of Use Thereof CLASP1, CLTC, CD47 ALDH1A1 2977/4885TSHR 225/4885MEN1 173/4885
US-12453785-B2 Macrocyclic chelators and methods of use thereof CLASP1, CLTC, CD47 ALDH1A1 2977/4885TSHR 225/4885MEN1 173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.